Advertisement

Experience with 5FU + L-Leucovorin

  • C. Erlichman
  • S. Fine
  • I. Kerr
  • W. Hoffman
  • C. Gorg
  • H.-J. Schmoll
  • P. Preusser
  • H.-J. Senn
  • B. Gustavsson
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 339)

Abstract

The mainstay of treatment for patients with metastatic colorectal cancer is chemotherapy with the combination of 5-Fluorouracil (5FU) and Leucovorin (LV) 1. This treatment has resulted in a response rate of 23% compared to 11% for 5FU in nine randomized trials of patients with previously untreated metastatic colorectal cancer 2. When compared to 5FU the odds ratio for response was 0.45 favouring 5FU + LV. The clinical modulation of 5FU antitumor effects supported the experimental studies in which the addition of LV in vitro led to increased cytotoxicity. This was related to stabilization of the thymidylate synthase (TS) folate and fluorodeoxyuridine monophosphate (FdUMP) complex and increased TS inhibition. Many questions of regarding the optimal dose of 5FU and LV and schedule of adminstration remain unresolved at present. The importance of the 1-LV in the antitumor effect of 5FU and the potential for interference of d-LV in the action of 1-LV must also be addressed.

Keywords

Clin Oncol Metastatic Colorectal Cancer Folinic Acid Racemic Mixture Advanced Colorectal Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Erlichman C, Fine S, Wong A, Elhakim T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988; 6: 469–75.PubMedGoogle Scholar
  2. 2.
    The advanced colorectal cancer meta-analysis project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 1992; 10: 896–903.Google Scholar
  3. 3.
    Machover D, Grison X, Goldschmidt E, et al. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma — A phase-I-II study. J Nat Cancer Inst 1992; 84: 321–327.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • C. Erlichman
    • 1
  • S. Fine
    • 2
  • I. Kerr
    • 3
  • W. Hoffman
    • 4
  • C. Gorg
    • 5
  • H.-J. Schmoll
    • 6
  • P. Preusser
    • 7
  • H.-J. Senn
    • 8
  • B. Gustavsson
    • 9
  1. 1.Princess Margaret HospitalTorontoCanada
  2. 2.Credit Valley HospitalMississaugaCanada
  3. 3.Sunnybrook Medical CentreTorontoCanada
  4. 4.City Hospital LeverkusenLeverkusenGermany
  5. 5.Phillipps UniversityMarburgGermany
  6. 6.Hannover Medical UniversityHannoverGermany
  7. 7.University HospitalMunsterGermany
  8. 8.KantonsspitalSt. GallenSwitzerland
  9. 9.East HospitalGothenburgSweden

Personalised recommendations